Cargando…

Assessing the long-term safety and efficacy of COVID-19 vaccines

Detalles Bibliográficos
Autores principales:	Majeed, Azeem, Papaluca, Marisa, Molokhia, Mariam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276333/ https://www.ncbi.nlm.nih.gov/pubmed/33945346 http://dx.doi.org/10.1177/01410768211013437

Ejemplares similares

Healthier schools during the COVID-19 pandemic: ventilation, testing and vaccination
por: Asanati, Kaveh, et al.
Publicado: (2021)

Current and future perspectives on the management of polypharmacy
por: Molokhia, Mariam, et al.
Publicado: (2017)

The future role of the GP Quality and Outcomes Framework in England
por: Majeed, Azeem, et al.
Publicado: (2023)

COVID-19 vaccine allocation: addressing the United Kingdom’s colour-blind strategy
por: Osama, Tasnime, et al.
Publicado: (2021)

COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines
por: Islam, Nazrul, et al.
Publicado: (2020)

Risk of COVID-19 in shielded and nursing care home patients: a cohort study in general practice
por: Wingfield, David, et al.
Publicado: (2021)

Prioritising the global response to curb the spread of COVID-19 in the fragile settings of the Global South
por: Osama, Tasnime, et al.
Publicado: (2020)

Protecting older people from COVID-19: should the United Kingdom start at age 60?
por: Osama, Tasnime, et al.
Publicado: (2020)

Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991–2006
por: Molokhia, Mariam, et al.
Publicado: (2008)

The primary care response to COVID-19 in England's National Health Service
por: Majeed, Azeem, et al.
Publicado: (2020)

COVID-19 presents opportunities and threats to transport and health
por: Laverty, Anthony A, et al.
Publicado: (2020)

Maximising the impact of social prescribing on population health in the era of COVID-19
por: Younan, Helen-Cara, et al.
Publicado: (2020)

Precision Medicine in Non-Communicable Diseases
por: Novelli, Giuseppe, et al.
Publicado: (2020)

Long term consequences of COVID-19
por: Berenguera, Anna, et al.
Publicado: (2021)

Planning for COVID-19 vaccines safety surveillance
por: Kochhar, Sonali, et al.
Publicado: (2020)

Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?
por: Beaney, Thomas, et al.
Publicado: (2020)

Developing standard safety outcomes for COVID-19 vaccines
por: Buttery, Jim P.
Publicado: (2021)

Long-term care and COVID-19: An equitable recovery
por: Rubano, Mario D., et al.
Publicado: (2022)

Commentary: Coronavirus disease 2019 (COVID-19): The long (term) and short (term) of it
por: Wisniewski, Alex M., et al.
Publicado: (2021)

Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection
por: Bizimungu, Christelle, et al.
Publicado: (2023)

Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005
por: Patel, Hitesh, et al.
Publicado: (2007)

COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER)
por: Kochhar, Sonali, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety
por: Kricorian, Katherine, et al.
Publicado: (2021)

Moving targets: COVID-19 vaccine efficacy against Omicron subvariants
por: da Silva, Maria Karolaynne, et al.
Publicado: (2022)

Developing a shared definition of self-driven healthcare to enhance the current healthcare delivery paradigm
por: El-Osta, Austen, et al.
Publicado: (2022)

Commentary: Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
por: Kumar, Atul, et al.
Publicado: (2018)

Key social science priorities for long-term COVID-19 response
por: Lees, Shelley, et al.
Publicado: (2021)

Education in and After Covid-19: Immediate Responses and Long-Term Visions
por: Zhu, Xudong, et al.
Publicado: (2020)

Industry 4.0 Technologies for the Manufacturing and Distribution of COVID-19 Vaccines
por: Sarfraz, Azza, et al.
Publicado: (2022)

Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
por: Su, Shan, et al.
Publicado: (2021)

Long-term efficacy and safety of human papillomavirus vaccination
por: De Vincenzo, Rosa, et al.
Publicado: (2014)

Journal Club: Remote infection control assessments in long-term care facilities during COVID-19 pandemic in Texas, 2020
por: Merrill, Katreena, et al.
Publicado: (2022)

Safety vs. efficacy assessment of pharmaceuticals: Epistemological rationales and methods
por: Osimani, Barbara
Publicado: (2014)

Healthcare workers potentially exposed to HIV: an update
por: Asanati, Kaveh, et al.
Publicado: (2022)

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?
por: Miller, Elizabeth
Publicado: (2022)

Obligation Is Not a Compulsion—The Quality of the Law and the Effectiveness and Safety of Vaccination against COVID-19
por: Kocańda, Kamila, et al.
Publicado: (2022)

Long-term care settings in the times of COVID-19: challenges and future directions
por: Ayalon, Liat, et al.
Publicado: (2020)

Commentary: Long-term solutions to revive eye banking in India in COVID-19 era - Needs more than long-term corneal preservation
por: Basak, Samar K, et al.
Publicado: (2020)

Determinants of long‐term opioid prescribing in an urban population: A cross‐sectional study
por: Naughton, Michael, et al.
Publicado: (2022)

Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_orlbc3ksi5ej9mt347e2iiumli